Publication | Closed Access

Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells

Chemoprevention StrategyGliomaMedicineIntegrin AntagonistsU87mg Glioma CellsAnti-cancer AgentSingle CellPharmacologyCell BiologyTumor Biology